Clinical Trial Update: Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing continuous versus short infusions of ceftazidime in cystic fibrosis patients with Pseudomonas aeruginosa was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pseudomonas Aeruginosa Infection
• Pulmonary Exacerbation

Drugs mentioned

• ceftazidime (ceftazidime)

Snippet

Sponsor: Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche | Conditions: Cystic Fibrosis, Pseudomonas Aeruginosa | Phase 4 | Status: TERMINATED